Helix BioMedix (HXBM) Filings

CT ORDER

Confidential treatment order

26 Dec 19

D

$5.63M in debt / options / securities to be acquired, sold $5.63M, 1 investor

30 Jul 19

CT ORDER

Confidential treatment order

5 Feb 18

CT ORDER

Confidential treatment order

3 Oct 17

CT ORDER

Confidential treatment order

29 Jan 15

D

$4.5M in debt / options / securities to be acquired, sold $1M, 1 investor

3 Dec 14

CT ORDER

Confidential treatment order

12 Feb 14

CT ORDER

Confidential treatment order

17 Jul 13

CT ORDER

Confidential treatment order

1 Jul 13

D

$4.5M in equity / options / securities to be acquired, sold $500K, 1 investor

1 May 13

SC 13E3/A

Going private transaction (amended)

8 Jan 13

15-15D

Suspension of duty to report

2 Jan 13

S-8 POS

Registration of securities for employees (post-effective amendment)

31 Dec 12

S-8 POS

Registration of securities for employees (post-effective amendment)

31 Dec 12

8-K

Submission of Matters to a Vote of Security Holders

28 Dec 12

CORRESP

Correspondence with SEC

19 Nov 12

SC 13E3/A

Going private transaction (amended)

19 Nov 12

UPLOAD

Letter from SEC

16 Nov 12

SC 13E3/A

Going private transaction (amended)

14 Nov 12

CORRESP

Correspondence with SEC

13 Nov 12

UPLOAD

Letter from SEC

1 Nov 12

CORRESP

Correspondence with SEC

23 Oct 12

PRER14A

Preliminary revised proxy

23 Oct 12

SC 13E3/A

Going private transaction (amended)

23 Oct 12

UPLOAD

Letter from SEC

5 Oct 12

CT ORDER

Confidential treatment order

20 Sep 12

8-K

Helix BioMedix Announces Plan for Voluntary Suspension of SEC Reporting Obligations

11 Sep 12

DEFA14A

Additional proxy soliciting materials

11 Sep 12

PRE 14A

Preliminary proxy

11 Sep 12

SC 13E3

Going private transaction

11 Sep 12

8-K

Submission of Matters to a Vote of Security Holders

24 May 12

ARS

2011 FY

Annual report to shareholders

16 Apr 12

8-K

Entry into a Material Definitive Agreement

12 Apr 12

DEF 14A

Definitive proxy

9 Apr 12